IL156174A0 - 1,2,4-oxadizaole derivatives as hppar alpha agonists - Google Patents

1,2,4-oxadizaole derivatives as hppar alpha agonists

Info

Publication number
IL156174A0
IL156174A0 IL15617401A IL15617401A IL156174A0 IL 156174 A0 IL156174 A0 IL 156174A0 IL 15617401 A IL15617401 A IL 15617401A IL 15617401 A IL15617401 A IL 15617401A IL 156174 A0 IL156174 A0 IL 156174A0
Authority
IL
Israel
Prior art keywords
oxadizaole
derivatives
alpha agonists
hppar alpha
hppar
Prior art date
Application number
IL15617401A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL156174A0 publication Critical patent/IL156174A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL15617401A 2000-12-08 2001-12-06 1,2,4-oxadizaole derivatives as hppar alpha agonists IL156174A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029974.3A GB0029974D0 (en) 2000-12-08 2000-12-08 Chemical compounds
PCT/GB2001/005400 WO2002046174A1 (en) 2000-12-08 2001-12-06 1, 2, 4-oxadiazole derivatives as hppar alpha agonists

Publications (1)

Publication Number Publication Date
IL156174A0 true IL156174A0 (en) 2003-12-23

Family

ID=9904715

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15617401A IL156174A0 (en) 2000-12-08 2001-12-06 1,2,4-oxadizaole derivatives as hppar alpha agonists
IL156174A IL156174A (en) 2000-12-08 2003-05-28 1,2,4-oxadiazole derivatives and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL156174A IL156174A (en) 2000-12-08 2003-05-28 1,2,4-oxadiazole derivatives and pharmaceutical compositions containing them

Country Status (13)

Country Link
US (1) US7141591B2 (cs)
EP (1) EP1355890A1 (cs)
AU (2) AU2002220902B2 (cs)
CA (1) CA2430847A1 (cs)
CZ (1) CZ20031581A3 (cs)
GB (1) GB0029974D0 (cs)
IL (2) IL156174A0 (cs)
MX (1) MXPA03005008A (cs)
NO (1) NO20032582L (cs)
NZ (1) NZ526251A (cs)
PL (1) PL360974A1 (cs)
WO (1) WO2002046174A1 (cs)
ZA (1) ZA200304312B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7205321B2 (en) 2001-11-15 2007-04-17 Eli Lilly And Company Peroxisome proliferator activated receptor alpha agonists
GB0214139D0 (en) * 2002-06-19 2002-07-31 Glaxo Group Ltd Chemical compounds
BR0312503A (pt) * 2002-07-09 2007-06-26 Bristol Myers Squibb Co derivados heterocìclicos substituìdos úteis como agentes antidiabéticos e antiobesidade, composição farmacêutica, uso e combinação dos mesmos
CA2549385A1 (en) 2003-12-22 2005-07-21 Eli Lilly And Company Triazole, oxadiazole and thiadiazole derivative as ppar modulators for the treatment of diabetes
JP5069813B2 (ja) * 2010-10-14 2012-11-07 第一三共株式会社 アシルベンゼン誘導体
PH12014500251A1 (en) * 2011-07-29 2014-03-17 Daiichi Sankyo Co Ltd N-hetero-ring-substituted amide derivative
IN2014MN01442A (cs) * 2012-01-18 2015-07-03 Daiichi Sankyo Co Ltd

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE292622T1 (de) * 1997-01-22 2005-04-15 Aventis Pharma Inc Substituierte beta-thiocarbonsäuren
PL351470A1 (en) 1999-04-28 2003-04-22 Aventis Pharma Gmbh Tri-aryl acid derivatives as ppar receptor ligands
US6417212B1 (en) 1999-08-27 2002-07-09 Eli Lilly & Company Modulators of peroxisome proliferator activated receptors
US6875780B2 (en) * 2002-04-05 2005-04-05 Warner-Lambert Company Compounds that modulate PPAR activity and methods for their preparation

Also Published As

Publication number Publication date
NO20032582L (no) 2003-08-07
NO20032582D0 (no) 2003-06-06
US20040132787A1 (en) 2004-07-08
WO2002046174A1 (en) 2002-06-13
MXPA03005008A (es) 2003-09-05
IL156174A (en) 2008-11-03
ZA200304312B (en) 2004-10-13
CZ20031581A3 (cs) 2003-08-13
GB0029974D0 (en) 2001-01-24
AU2090202A (en) 2002-06-18
NZ526251A (en) 2006-03-31
EP1355890A1 (en) 2003-10-29
US7141591B2 (en) 2006-11-28
CA2430847A1 (en) 2002-06-13
AU2002220902B2 (en) 2005-06-02
PL360974A1 (en) 2004-09-20

Similar Documents

Publication Publication Date Title
IL154604A0 (en) Guanidinobenzamides as mc4-r agonists
IL160708A0 (en) 1, 6-naphthyridine derivatives as antidiabetics
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
EG22695A (en) Novel phenyl-propargylether derivatives
AU3740101A (en) 2,4-disubstituted thiazolyl derivatives
ZA200100900B (en) 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists.
HRP20020962A2 (en) Benzothiazole derivatives
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
ZA200207489B (en) Apomorphine derivatives and methods for their use.
MXPA03008140A (es) Amidas de acido benzofuran-2-carboxilico sustituidas.
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
GB0026467D0 (en) Compound, composition and use
ZA200205482B (en) Aminosulfonylbiphenyl derivatives.
HUP0300562A3 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the
ZA200206151B (en) Substituted amionomethyl-phenyl-cyclohexane derivatives.
MXPA03002737A (es) Derivados sustituidos de 1-aminobutan-3-ol.
MXPA03001269A (es) Nuevos derivados de aminociclohexano.
MXPA02005011A (es) Nuevos derivados de tiazolidindiona como agentes antidiabeticos.
IL156174A0 (en) 1,2,4-oxadizaole derivatives as hppar alpha agonists
ZA200206150B (en) Aminomethyl-phenyl-cyclohexanone derivatives.
MXPA01000464A (es) Composicion.
MXPA03008394A (es) Derivados de biuretano.
GB0005301D0 (en) Compound, composition and use
MXPA03002734A (es) Derivados de 5-amino-1-penten-3-ol sustituidos.
GB0005299D0 (en) Compound, compositions and use